Grossman H J, Grossman V L, Bhathal P S
Department of Pathology, University of Melbourne, Victoria, Australia.
J Gastroenterol Hepatol. 1992 May-Jun;7(3):283-7. doi: 10.1111/j.1440-1746.1992.tb00981.x.
Humoral vasoconstrictor factors in portal venous blood have an important influence on hepatic vascular tone. The aim of this study was to determine whether there is altered reactivity of the intrahepatic portal vascular bed of cirrhotic livers to such factors. Isolated perfused rat liver preparations (IPRLP) obtained from rats with carbon tetrachloride-induced cirrhosis and from normal controls were treated with small aliquots of fresh, heparinized venous blood (4% vol/vol) added to a synthetic perfusate composed of 2.5% bovine serum albumin in Krebs-Henseleit buffer. Compared with blood from the inferior vena cava, portal venous blood produced a greater increase in perfusion resistance of normal IPRLP (2.8 +/- 0.7 vs 15 +/- 3%, P less than 0.05). There was no significant difference in the response of normal IPRLP to portal venous blood obtained from cirrhotic animals compared with portal blood from normal controls (10 +/- 4 vs 15 +/- 3%). However, cirrhotic IPRLP were significantly (P less than 0.05) more responsive to portal venous blood than were control livers, regardless of whether the blood was obtained from control (28 +/- 6%) or cirrhotic (24 +/- 6%) rats. The response of both control and cirrhotic IPRLP to portal blood could be partially inhibited by the alpha-adrenoceptor antagonist phentolamine (5 x 10(-6) mol/L) and cirrhotic IPRLP were more responsive than controls to exogenous noradrenaline (518 +/- 27 vs 363 +/- 21%, P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
门静脉血中的体液性血管收缩因子对肝血管张力有重要影响。本研究的目的是确定肝硬化肝脏肝内门静脉血管床对此类因子的反应性是否改变。从四氯化碳诱导的肝硬化大鼠和正常对照大鼠获得的离体灌注大鼠肝脏标本(IPRLP),用小份新鲜的肝素化静脉血(4%体积/体积)处理,该静脉血添加到由2.5%牛血清白蛋白溶于Krebs-Henseleit缓冲液组成的合成灌注液中。与来自下腔静脉的血液相比,门静脉血使正常IPRLP的灌注阻力有更大增加(2.8±0.7对15±3%,P<0.05)。与来自正常对照的门静脉血相比,正常IPRLP对来自肝硬化动物的门静脉血的反应无显著差异(10±4对15±3%)。然而,无论血液是取自对照大鼠(28±6%)还是肝硬化大鼠(24±6%),肝硬化IPRLP对门静脉血的反应均显著(P<0.05)强于对照肝脏。α-肾上腺素能受体拮抗剂酚妥拉明(5×10⁻⁶mol/L)可部分抑制对照和肝硬化IPRLP对门静脉血的反应,且肝硬化IPRLP对外源性去甲肾上腺素的反应强于对照(518±27对363±21%,P<0.01)。(摘要截短于250字)